Next Article in Journal
3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders
Previous Article in Journal
A New Flavonoid C-Glycoside from Celtis australis L. and Celtis occidentalis L. Leaves and Potential Antioxidant and Cytotoxic Activities
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities

1
Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad-500 072, India
2
Project Management, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad-500 072, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(2), 215-232; https://doi.org/10.3797/scipharm.0912-14
Submission received: 15 December 2009 / Accepted: 2 March 2010 / Published: 5 March 2010

Abstract

New stability indicating chromatographic methods have been developed for estimation of Assay and Impurities of Docetaxel in Docetaxel injection for evaluation of pharmaceutical quality. With this method, the process related impurities and degradants are well separated from the peaks due to placebo. The relative retention times and relative response factors of the known impurities have been established. The LOQ of the known impurities and docetaxel are found to be less than 0.2 μg /ml and the recovery falls in the range of 90–110%. Peak purities demonstrated the stability indicating nature of the methods. The methods developed in the present study overcome the lacunae of the existing published methodologies in evaluation of the quality of Docetaxel injection. In essence, the present study provides an improved methodology for evaluation of the pharmaceutical quality of Docetaxel injection.
Keywords: HPLC; Quality; Stability indicating; Docetere; Impurities; Excipients HPLC; Quality; Stability indicating; Docetere; Impurities; Excipients

Share and Cite

MDPI and ACS Style

MALLESWARA REDDY, A.; BANDA, N.; GOVIND DAGDU, S.; RAO, D.V.; KOCHERLAKOTA, C.S.; KRISHNAMURTHY, V. Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities. Sci. Pharm. 2010, 78, 215-232. https://doi.org/10.3797/scipharm.0912-14

AMA Style

MALLESWARA REDDY A, BANDA N, GOVIND DAGDU S, RAO DV, KOCHERLAKOTA CS, KRISHNAMURTHY V. Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities. Scientia Pharmaceutica. 2010; 78(2):215-232. https://doi.org/10.3797/scipharm.0912-14

Chicago/Turabian Style

MALLESWARA REDDY, Annarapu, Nagaraju BANDA, Shinde GOVIND DAGDU, Dama Venugopala RAO, Chandra Sekhar KOCHERLAKOTA, and Vyas KRISHNAMURTHY. 2010. "Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities" Scientia Pharmaceutica 78, no. 2: 215-232. https://doi.org/10.3797/scipharm.0912-14

Article Metrics

Back to TopTop